Biosimilar names may affect pharmacist dispensing habits

(By Ed Silverman for STAT)

What’s in a name? An awful lot when it comes to biosimilars. Continue reading article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or